Ishani Patel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ishani Patel has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Anait S. Levenson
Department of Veterinary Biomedical Sciences, Lewyt College of Veterinary Medicine, Long Island University, Brookville, NY 11548, USA
4 shared publications - Avinash Kumar
Division of Pharmaceutical Sciences, Arnold & Marie Schwartz College of Pharmacy and Health Sciences, Long Island University, Brooklyn, NY 11201, USA
4 shared publications - Virginia Donovan
NYU Winthrop Hospital, Mineola, NY
4 shared publications - Gisella Campanelli
Department of Veterinary Biomedical Sciences, Lewyt College of Veterinary Medicine, Long Island University, Brookville, NY 11548, USA
2 shared publications Ninad Inamdar
2 shared publications- Rutu Hemani
Arnold & Marie Schwartz College of Pharmacy and Health Sciences, Long Island University, Brooklyn, New York
2 shared publications
Latest Publications
- Open Access
- 28 July 2023
- Published by Elsevier in Journal of Obstetric, Gynecologic, & Neonatal Nursing
- Vol. 52 (5) , 374-383
Food Insecurity and Food Access Among Women in Northern New England During the Perinatal Period
- 28 July 2023
- Published by Elsevier in Journal of Obstetric, Gynecologic, & Neonatal Nursing
- Vol. 52 (5) , 374-383
Open AccessFood Insecurity and Food Access Among Women in Northern New England During the Perinatal Period
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 1-2; Supplementary Table 1-4 from Dietary Pterostilbene for MTA1-Targeted Interception in High-Risk Premalignant Prostate Cancer
Supplementary Figure 1: A, transgene integration and genotyping scheme of MTA1 transgenic animals. B, genotyping of MTA1 founder 870#2. Supplementary Figure 2: A, average body weight of mice fed different diets during 22 weeks (monitored weekly). B, effect of PTER-Diet on food intake (g). Supplementary Table 1: Nutritional composition of diets. Supplementary Table 2: Primers for genotyping used in this study. Supplementary Table 3: Antibodies for immunoblots and IHC used in this study. Supplementary Table 4: Primers for qRT-PCR used in this study.
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 1-2; Supplementary Table 1-4 from Dietary Pterostilbene for MTA1-Targeted Interception in High-Risk Premalignant Prostate Cancer
Supplementary Figure 1: A, transgene integration and genotyping scheme of MTA1 transgenic animals. B, genotyping of MTA1 founder 870#2. Supplementary Figure 2: A, average body weight of mice fed different diets during 22 weeks (monitored weekly). B, effect of PTER-Diet on food intake (g). Supplementary Table 1: Nutritional composition of diets. Supplementary Table 2: Primers for genotyping used in this study. Supplementary Table 3: Antibodies for immunoblots and IHC used in this study. Supplementary Table 4: Primers for qRT-PCR used in this study.
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 1-2; Supplementary Table 1-4 from Dietary Pterostilbene for MTA1-Targeted Interception in High-Risk Premalignant Prostate Cancer
Supplementary Figure 1: A, transgene integration and genotyping scheme of MTA1 transgenic animals. B, genotyping of MTA1 founder 870#2. Supplementary Figure 2: A, average body weight of mice fed different diets during 22 weeks (monitored weekly). B, effect of PTER-Diet on food intake (g). Supplementary Table 1: Nutritional composition of diets. Supplementary Table 2: Primers for genotyping used in this study. Supplementary Table 3: Antibodies for immunoblots and IHC used in this study. Supplementary Table 4: Primers for qRT-PCR used in this study.
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 1-2; Supplementary Table 1-4 from Dietary Pterostilbene for MTA1-Targeted Interception in High-Risk Premalignant Prostate Cancer
Supplementary Figure 1: A, transgene integration and genotyping scheme of MTA1 transgenic animals. B, genotyping of MTA1 founder 870#2. Supplementary Figure 2: A, average body weight of mice fed different diets during 22 weeks (monitored weekly). B, effect of PTER-Diet on food intake (g). Supplementary Table 1: Nutritional composition of diets. Supplementary Table 2: Primers for genotyping used in this study. Supplementary Table 3: Antibodies for immunoblots and IHC used in this study. Supplementary Table 4: Primers for qRT-PCR used in this study.
- Open Access
- 1 January 2023
- Published by SAGE Publications in Women's Health
- Vol. 19
What is prenatal stress? A scoping review of how prenatal stress is defined and measured within the context of food insecurity, housing instability, and immigration in the United States
Background: Stress during pregnancy can lead to significant adverse outcomes for maternal mental health. Early evaluation of prenatal stress can help identify treatment needs and appropriate interventions. Disparities in the social determinants of health can contribute to stress, but what constitutes stress during pregnancy within the social determinants of health framework is poorly understood. Objective: To scope how prenatal stress is defined and measured among pregnant people exposed to three prominent social stressors in the United States: insecurity pertaining to food, housing, and immigration. Eligibility Criteria: We included all studies that focused on stress during pregnancy in the context of food insecurity, housing instability, and immigration, given their recent policy focus due to the COVID-19 pandemic and ongoing political discourse, in addition to their importance in American College of Obstetricians and Gynecologists (ACOG’s) social determinants of health screening tool. Sources of Evidence: We searched PubMed, Scopus, and Web of Science for articles published between January 2012 and January 2022. Charting Methods: Using a piloted charting tool, we extracted relevant study information from the selected articles and analyzed the content pertaining to stress. Results: An initial search identified 1,023 articles, of which 24 met our inclusion criteria. None of the studies defined prenatal stress, and only one used the Prenatal Distress Questionnaire, a prenatal stress-specific tool to measure it. The Perceived Stress Scale was the most common instrument used in seven studies. Fifteen studies measured over 25 alternative exposures that researchers theorized were associated with stress, and 4 of the 15 studies did not explain the association between the measure and stress. Conclusions: Our findings demonstrate a fundamental inconsistency in how prenatal stress is defined and measured in the context of social determinants of health, limiting the comparison of results across studies and the potential development of effective interventions to promote better maternal mental health.
- 1 January 2023
- Published by SAGE Publications in Women's Health
- Vol. 19
Open AccessWhat is prenatal stress? A scoping review of how prenatal stress is defined and measured within the context of food insecurity, housing instability, and immigration in the United States
Background: Stress during pregnancy can lead to significant adverse outcomes for maternal mental health. Early evaluation of prenatal stress can help identify treatment needs and appropriate interventions. Disparities in the social determinants of health can contribute to stress, but what constitutes stress during pregnancy within the social determinants of health framework is poorly understood. Objective: To scope how prenatal stress is defined and measured among pregnant people exposed to three prominent social stressors in the United States: insecurity pertaining to food, housing, and immigration. Eligibility Criteria: We included all studies that focused on stress during pregnancy in the context of food insecurity, housing instability, and immigration, given their recent policy focus due to the COVID-19 pandemic and ongoing political discourse, in addition to their importance in American College of Obstetricians and Gynecologists (ACOG’s) social determinants of health screening tool. Sources of Evidence: We searched PubMed, Scopus, and Web of Science for articles published between January 2012 and January 2022. Charting Methods: Using a piloted charting tool, we extracted relevant study information from the selected articles and analyzed the content pertaining to stress. Results: An initial search identified 1,023 articles, of which 24 met our inclusion criteria. None of the studies defined prenatal stress, and only one used the Prenatal Distress Questionnaire, a prenatal stress-specific tool to measure it. The Perceived Stress Scale was the most common instrument used in seven studies. Fifteen studies measured over 25 alternative exposures that researchers theorized were associated with stress, and 4 of the 15 studies did not explain the association between the measure and stress. Conclusions: Our findings demonstrate a fundamental inconsistency in how prenatal stress is defined and measured in the context of social determinants of health, limiting the comparison of results across studies and the potential development of effective interventions to promote better maternal mental health.
- 15 August 2020
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 80 (16_Supplem) , 3466
Abstract 3466: Can grape powder supplemented diet prevent prostate cancer progression
Epidemiological and experimental studies suggest a correlation between diet, particularly fat consumption and the risk of developing prostate cancer (PCa). In previous studies, we reported that stilbenes, namely resveratrol and pterostilbene, restrained prostatic intraepithelial neoplasia (PIN) formation and reduced tumor development and progression in mice models of PCa with high expression of metastasis-associated protein 1 (MTA1), an epigenetic modifier involved in the regulation of prostate cancer progression and metastasis. In this report, we evaluated three major aspects: 1) whether altering diet [low fat diet (LFD) versus high fat diet (HFD)] affects PCa progression; 2) whether grape powder (GP) supplementation to the diets protects against PCa progression, and 3) whether MTA1 targeting is the main mechanism of action. We addressed these questions by utilizing the prostate-specific (PB-Cre4) Pten heterozygous transgenic mice (Pten+/f), which mimic slow-growing PCa progression in humans. Upon accumulating 56 mice of desired genotype, we randomized mice in two major groups and fed them ad libitum with either LFD or HFD. Each of these diets contained either 0% GP or 10% GP supplementation. The same groups were assigned for control wild-type (WT) mice (Pten+/f; Cre-). After 33 weeks on corresponding diets, mice were sacrificed and urogenital system was collected for histological and immunochemical analysis. In addition, protein and RNA was isolated from the prostate tissues for molecular analysis. Blood was also collected for cytokines evaluation and pharmacokinetic analysis. The results demonstrated the following beneficial effects of GP supplementation: LFD and HFD - fed Pten+/f mice showed added favorable histopathology (H&E), intact basal layer (SMA) and luminal cells (CK-8); significant reduction of the proliferative rate of prostate epithelial cells (Ki67); non-significant trend for reducing HFD-induced MTA1 expression in Pten+/f and WT mice; protective effects against “bad” genotype and HFD-induced activation of Akt pathway; attenuation of HFD-associated increase in AR levels in both Pten+/f and WT mice; reduction of HFD-provoked increased inflammation marker IL-1β levels; non-significant trend for reducing angiogenesis (CD31; VEGF-C) in Pten+/f mice; and trend towards decreasing inflammatory TGFβ1 expression in Pten+/f mice. Curious results were obtained concerning the effect of GP on apoptosis. There were no significant changes in body weight, food intake or fat intake in GP supplemented diets groups. Citation Format: Tanvi Joshi, Ishani Patel, Avinash Kumar, Virginia Donovan, Anait S. Levenson. Can grape powder supplemented diet prevent prostate cancer progression [abstract]. In: Proceedings of the Annual Meeting of the American Association for Cancer Research 2020; 2020 Apr 27-28 and Jun 22-24. Philadelphia (PA): AACR; Cancer Res 2020;80(16 Suppl):Abstract nr 3466.
- 15 August 2020
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 80 (16_Supplem) , 3466
Abstract 3466: Can grape powder supplemented diet prevent prostate cancer progression
Epidemiological and experimental studies suggest a correlation between diet, particularly fat consumption and the risk of developing prostate cancer (PCa). In previous studies, we reported that stilbenes, namely resveratrol and pterostilbene, restrained prostatic intraepithelial neoplasia (PIN) formation and reduced tumor development and progression in mice models of PCa with high expression of metastasis-associated protein 1 (MTA1), an epigenetic modifier involved in the regulation of prostate cancer progression and metastasis. In this report, we evaluated three major aspects: 1) whether altering diet [low fat diet (LFD) versus high fat diet (HFD)] affects PCa progression; 2) whether grape powder (GP) supplementation to the diets protects against PCa progression, and 3) whether MTA1 targeting is the main mechanism of action. We addressed these questions by utilizing the prostate-specific (PB-Cre4) Pten heterozygous transgenic mice (Pten+/f), which mimic slow-growing PCa progression in humans. Upon accumulating 56 mice of desired genotype, we randomized mice in two major groups and fed them ad libitum with either LFD or HFD. Each of these diets contained either 0% GP or 10% GP supplementation. The same groups were assigned for control wild-type (WT) mice (Pten+/f; Cre-). After 33 weeks on corresponding diets, mice were sacrificed and urogenital system was collected for histological and immunochemical analysis. In addition, protein and RNA was isolated from the prostate tissues for molecular analysis. Blood was also collected for cytokines evaluation and pharmacokinetic analysis. The results demonstrated the following beneficial effects of GP supplementation: LFD and HFD - fed Pten+/f mice showed added favorable histopathology (H&E), intact basal layer (SMA) and luminal cells (CK-8); significant reduction of the proliferative rate of prostate epithelial cells (Ki67); non-significant trend for reducing HFD-induced MTA1 expression in Pten+/f and WT mice; protective effects against “bad” genotype and HFD-induced activation of Akt pathway; attenuation of HFD-associated increase in AR levels in both Pten+/f and WT mice; reduction of HFD-provoked increased inflammation marker IL-1β levels; non-significant trend for reducing angiogenesis (CD31; VEGF-C) in Pten+/f mice; and trend towards decreasing inflammatory TGFβ1 expression in Pten+/f mice. Curious results were obtained concerning the effect of GP on apoptosis. There were no significant changes in body weight, food intake or fat intake in GP supplemented diets groups. Citation Format: Tanvi Joshi, Ishani Patel, Avinash Kumar, Virginia Donovan, Anait S. Levenson. Can grape powder supplemented diet prevent prostate cancer progression [abstract]. In: Proceedings of the Annual Meeting of the American Association for Cancer Research 2020; 2020 Apr 27-28 and Jun 22-24. Philadelphia (PA): AACR; Cancer Res 2020;80(16 Suppl):Abstract nr 3466.
- Open Access
- 12 July 2020
- Published by Wiley in Molecular Nutrition & Food Research
- Vol. 64 (16) , e2000326
Grape Powder Supplementation Attenuates Prostate Neoplasia Associated with Pten Haploinsufficiency in Mice Fed High‐Fat Diet
Scope: Previous studies have identified potent anticancer activities of polyphenols in preventing prostate cancer. The aim of the current study is to evaluate the chemopreventive potential of grape powder (GP) supplemented diets in genetically predisposed and obesity‐provoked prostate cancer.Methods and results: Prostate‐specific Pten heterozygous (Pten+/f) transgenic mice are fed low‐ and high‐fat diet (LFD and HFD, respectively) supplemented with 10% GP for 33 weeks, ad libitum. Prostate tissues are characterized using immunohistochemistry and western blots, and sera are analyzed by ELISA and qRT‐PCR. Pten+/f mice fed LFD and HFD supplemented with 10% GP show favorable histopathology, significant reduction of the proliferative rate of prostate epithelial cells (Ki67), and rescue of PTEN expression. The most potent protective effect of GP supplementation is detected against HFD‐induced increase in inflammation (IL‐1β; TGF‐β1), activation of cell survival pathways (Akt, AR), and angiogenesis (CD31) in Pten+/f mice. Moreover, GP supplementation reduces circulating levels of oncogenic microRNAs (miR‐34a; miR‐22) in Pten+/f mice. There are no significant changes in body weight and food intake in GP supplemented diet groups.Conclusions: GP diet supplementation can be a beneficial chemopreventive strategy for obesity‐related inflammation and prostate cancer progression. Monitoring serum miRNAs can facilitate the non‐invasive evaluation of chemoprevention efficacy.
- 12 July 2020
- Published by Wiley in Molecular Nutrition & Food Research
- Vol. 64 (16) , e2000326
Open AccessGrape Powder Supplementation Attenuates Prostate Neoplasia Associated with Pten Haploinsufficiency in Mice Fed High‐Fat Diet
Scope: Previous studies have identified potent anticancer activities of polyphenols in preventing prostate cancer. The aim of the current study is to evaluate the chemopreventive potential of grape powder (GP) supplemented diets in genetically predisposed and obesity‐provoked prostate cancer.Methods and results: Prostate‐specific Pten heterozygous (Pten+/f) transgenic mice are fed low‐ and high‐fat diet (LFD and HFD, respectively) supplemented with 10% GP for 33 weeks, ad libitum. Prostate tissues are characterized using immunohistochemistry and western blots, and sera are analyzed by ELISA and qRT‐PCR. Pten+/f mice fed LFD and HFD supplemented with 10% GP show favorable histopathology, significant reduction of the proliferative rate of prostate epithelial cells (Ki67), and rescue of PTEN expression. The most potent protective effect of GP supplementation is detected against HFD‐induced increase in inflammation (IL‐1β; TGF‐β1), activation of cell survival pathways (Akt, AR), and angiogenesis (CD31) in Pten+/f mice. Moreover, GP supplementation reduces circulating levels of oncogenic microRNAs (miR‐34a; miR‐22) in Pten+/f mice. There are no significant changes in body weight and food intake in GP supplemented diet groups.Conclusions: GP diet supplementation can be a beneficial chemopreventive strategy for obesity‐related inflammation and prostate cancer progression. Monitoring serum miRNAs can facilitate the non‐invasive evaluation of chemoprevention efficacy.